NCT05460741

Brief Summary

The study will determine the effects of integrated exercise approach on strength, postural stability and biomarkers (estrogen, progesterone and testosterone) of menstrual cycle in eumenorrheic females and translation of Unified Balance Scale will be done.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 15, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2024

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

2 years

First QC Date

May 31, 2022

Last Update Submit

April 29, 2024

Conditions

Keywords

exercise performancemenstrual cyclesex steroid hormones

Outcome Measures

Primary Outcomes (1)

  • ELISA

    progesterone, testosterone and estrogen of the females with no menstrual cycle dysfunction will be documented at baseline and then the exercise plan along with menstrual cycle education will be given to one group and just educational program will be given to other. the biomarkers will then be assesd after 2 months and at the end of study i.e, after 4 months.The unit of measurement of progesterone is ng/ml. progesterone is less than 1.5ng/ml in follicular phase, greater than 3ng/ml in ovulatory phase and 2 to 25ng/ml in luteal phase, testosterone is measured in nmol/L, being 0.32nmol/L in follicular phase and 0.35nmol/L in ovulatory and luteal phase. estrogen measured in pg/ml, being less than 50pg/ml in follicular phase, 400 pg/ml in ovulatory phase and upto 200pg/ml in luteal phase.this test has 68% sensitivity and 98% specificity

    4 months

Secondary Outcomes (2)

  • hand held dynamometer

    4 months

  • pressure biofeedback unit

    4 months

Other Outcomes (1)

  • global postural system

    4 months

Study Arms (2)

integrated exercise approach

EXPERIMENTAL

an integrated exercise will be used which is the exercise plan that will be formulated using strengthening and endurance exercises.

Other: integrated exercise approach

eumenhorreic females

EXPERIMENTAL

strength, postural stability and biomarkers of menstrual cycle in eumenhorreic females.

Other: educational program

Interventions

Integrated exercise plan will be given for 16 weeks with frequency of 3 times per week, with duration of session to be 50 minutes being 30 minutes of exercise in total and 10 minutes of rest and 10 min of warm up and cool down exercises.

Also known as: educational program
integrated exercise approach

educational program related to menstrual cycle will be given to females.

eumenhorreic females

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsfemales having no problem in menstrual cycle
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Females between the ages of 18 to 40 years.
  • Females having BMI between 18.5 to 24.9 (normal)
  • Females being able to maintain sitting balance independently without using upper limbs or having score of 25 on trunk control test.

You may not qualify if:

  • Females having oral contraceptives.
  • Females who are pregnant.
  • Females who have any menstruation issues like endometriosis, ovarian cysts etc
  • Females who have c section 6 months ago.
  • Females who are lactating.
  • Females having other co morbidities like cardiac event, seizures, any injury that will affect the study.
  • Females having history of fall 6 months ago.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Society

Lahore, Punjab Province, 40050, Pakistan

Location

Related Publications (6)

  • Rocha-Rodrigues S, Sousa M, Lourenco Reis P, Leao C, Cardoso-Marinho B, Massada M, Afonso J. Bidirectional Interactions between the Menstrual Cycle, Exercise Training, and Macronutrient Intake in Women: A Review. Nutrients. 2021 Jan 29;13(2):438. doi: 10.3390/nu13020438.

    PMID: 33572821BACKGROUND
  • Kitajima Y, Ono Y. Estrogens maintain skeletal muscle and satellite cell functions. J Endocrinol. 2016 Jun;229(3):267-75. doi: 10.1530/JOE-15-0476. Epub 2016 Apr 5.

    PMID: 27048232BACKGROUND
  • Le J, Thomas N, Gurvich C. Cognition, The Menstrual Cycle, and Premenstrual Disorders: A Review. Brain Sci. 2020 Mar 27;10(4):198. doi: 10.3390/brainsci10040198.

    PMID: 32230889BACKGROUND
  • Smith MJ, Adams LF, Schmidt PJ, Rubinow DR, Wassermann EM. Effects of ovarian hormones on human cortical excitability. Ann Neurol. 2002 May;51(5):599-603. doi: 10.1002/ana.10180.

    PMID: 12112106BACKGROUND
  • Shahid W, Noor R. Effects of integrated exercise approach on total testosterone levels in eumenorrheic women: a randomized controlled trial. Sci Rep. 2025 May 5;15(1):15692. doi: 10.1038/s41598-025-00599-x.

  • Shahid W, Noor R. Impact of BRACTS exercises on muscular strength in eumenorrheic women. Sci Rep. 2025 Feb 5;15(1):4430. doi: 10.1038/s41598-025-87352-6.

Study Officials

  • Rabiya Noor, phd*

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: there will be 2 groups. one will be given the education related to menstrual cycle and other will be given intervention along with education. then the outcomes will be assessed at multiple times of study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2022

First Posted

July 15, 2022

Study Start

March 15, 2022

Primary Completion

February 25, 2024

Study Completion

March 15, 2024

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations